Activated Bacterial Therapeutics (ABT) for Advanced Healing
Activation leverages the natural ability of good bacteria to form biofilms. This enhances activity within the GI tract and provides a strategic advantage when developing bacterial therapeutics.
Enabling the Delivery of Therapeutics Bacteria
Enabling the delivery of activated, live bacterial therapeutics (LBTs) capable of persisting in the gut and primed for interaction within the intestinal mucosa using our ABT technology will serve several unmet medical needs.
Enhanced Efficacy for Improved Lifestyles
Our solution is focused on the activation of beneficial bacteria that have the potential to advance healing in the GI tract as well as realizing the therapeutic potential of the gut-brain axis.
Our Platform
Scioto’s ABT Platform will revolutionize how bacteria are used as therapeutics.
Learn More
Our Pipeline
Scioto is working to meet unmet medical needs of the GI tract and central nervous system.
Learn More
Our Team
Scioto is built around the talent of scientists and experienced biotechnology executives dedicated to improving the lives of patients.
Learn MorePartnerships
NEC Society does not endorse any product or company, and does not create, sponsor, or authorize the content of any communications, surveys, programs, or incentives from any company. NEC Society is a registered word mark of its owner and its use does not imply any affiliation, endorsement, or sponsorship by them.
Company News
Optimizing Microbiome Delivery
Optimizing microbiome delivery for the benefit of children and adults with autism and GI disorders.